Intai Technology Corp.

Intai Technology Corp.

TTPEX:4163
125.50
TWD
0.00
(0.00%)
5.98EPS
20.00P/E
6.18BMarket Cap
Nov 05Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
31.1
37.06
38.71
42.17
37.25
39.17
48.19
40.61
40.86
49.98
50.63
49.18
49.42
50.88
Basic EPS, GAAP
5
6.5
6.04
7.23
3.11
5.99
7.54
5.11
4.73
8.75
7.05
5.38
5.13
6.1
Free Cash Flow per Basic Share
4.42
3.35
3.72
8.87
3
3.47
7.7
1.08
-6.23
0.39
3.96
1.34
5.6
8.09
Dividend per Share
2.48
4.13
4.13
3.72
4.96
1.9
3.75
4.17
3.5
2.5
4
3.5
3.5
- -
Book Value per Share
23.47
26.51
28.28
31.54
29.43
33.5
37.78
38.5
39.89
46.68
49.59
52.47
54.53
53.35
Tangible Book Value per Share
23.22
25.99
27.66
30.96
28.87
32.77
37.1
37.04
38.3
45.23
48.29
51.34
53.48
52.43
Basic Weighted Avg Shares
49
49
49
49
49
49
48
48
48
48
48
48
49
49
Sales/Revenue/Turnover
1,514
1,804
1,885
2,053
1,814
1,907
2,327
1,961
1,973
2,413
2,445
2,376
2,405
2,488
Operating Margin (%)
16.76
17.88
16.55
19.49
14.18
16.35
19.21
16.87
11.29
15.87
15.7
10.18
11.79
11.35
Depreciation Expense
49
55
65
70
76
77
101
105
115
121
138
163
177
186
Net Income, GAAP
243
316
294
352
152
292
364
247
228
422
341
260
250
298
Effective Tax Rate (%)
15.34
13.41
18.32
16.37
22.55
20.8
21.2
18.18
17.63
20.04
21.73
18.98
18.87
19.2
Profit Margin (%)
16.08
17.54
15.6
17.14
8.36
15.3
15.64
12.59
11.58
17.5
13.93
10.94
10.38
11.99
Working Capital
358
859
469
1,077
505
1,087
1,199
1,142
1,127
1,104
1,738
1,403
1,212
1,038
LT Debt
- -
458
- -
476
- -
499
592
662
830
851
1,397
1,122
890
726
Total Equity
1,143
1,291
1,377
1,536
1,433
1,631
1,847
1,863
1,934
2,257
2,535
2,673
2,771
2,762
Return on Invested Capital (%)
15.03
17.57
13.67
15.46
8.24
9.92
13.81
9.87
5.93
8.65
7.4
4.66
5.56
5.57
Return on Capital (%)
17.69
20.56
16.49
17
6.77
12.28
14.91
9.57
7.97
12.62
9.11
6.92
6.83
7.92
Return on Common Equity (%)
22.47
26.01
22.04
24.17
10.21
19.04
20.97
13.35
12.07
20.21
14.42
10.24
9.38
11.42

Capital Structure

TWD

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
565
567
574
LT Borrowings
834
719
673
LT Finance Leases
56
53
53
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
50
51
51
Market Capitalization
4,573
5,172
6,183

Working Capital

TWD

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
2,283
2,305
2,195
Cash, Cash Equivalents & STI
991
993
814
Accounts Receivable, Net
387
380
433
Inventories
860
871
887
Total Current Liabilities
1,071
1,266
1,157
Payables & Accruals
- -
- -
- -
ST Debt
565
567
574
Deferred Revenue
- -
- -
- -

Growth Rates

TWD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
7.47%
8.38%
3.67%
Free Cash Flow
51.6%
78.85%
321.77%
Net Income, GAAP
7.82%
6.08%
-3.96%
Sales/Revenue/Turnover
3.13%
4.53%
1.22%
Total Cash Common Dividend
7.21%
0.73%
0.74%

Quarterly Revenue

TWD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
603
605
589
579
2,376
2025
612
609
606
578
2,405
2026
623
682
- -
- -
- -

Quarterly Earnings Per Share

TWD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1.77
1.24
0.91
1.46
5.38
2025
1.67
0.29
1.59
1.57
5.13
2026
1.29
1.65
- -
- -
- -

Quarterly Dividends Per Share

TWD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
3.5
2025
- -
- -
- -
- -
3.5
2026
- -
- -
- -
- -
- -

Company Description

CEO
Chun Nan Lin
Full Time Employees
460
Sector
Producer manufacturing
Industry
Miscellaneous manufacturing
Address
9 Jingke Road Taichung TX Taiwan 408
IPO Date
Oct 24, 2011
Business
INTAI Technology Corporation, founded in 1988 and headquartered in Taichung, Taiwan, manufactures precision components and assemblies for the medical device, automotive, aerospace, precision hardware, and electronic communication industries in Taiwan and internationally; its core offerings include standard and customized precision hardware products such as metal machining, forming, material removal, and gear manufacturing; medical components for endoscopic minimally invasive surgery, breast biopsy devices, disposable and reusable applications, orthopedic implants including thoracolumbar and cervical sets, pedicle screws, PEEK and titanium cages, trauma screws and plates, and surgical instruments; RF and microwave products for commercial, wireless, automotive, and telecommunication sectors; as well as advanced processes encompassing molding via injection and metal injection molding (MIM), secondary operations like shaping, lapping, grinding, surface treatment, coating, and heat treatment, laser manufacturing for cutting, welding, and marking, unique material applications including Nitinol and coiling, and full assembly services in ISO 13485-certified and FDA-registered facilities. The company operates facilities including its JingKe headquarters established in 2012 in Taichung Precision Machinery Innovation Technology Park and the HouLi facility opened in 2023 to support expanded capacity. In 2025, INTAI participated as a new investor in Imperative Care's oversubscribed Series E financing round potentially reaching $150 million, led by Ally Bridge Group, underscoring its strategic push into medical technology investments alongside ongoing enhancements in vacuum heat-treatment furnaces and lean manufacturing implemented since 2015.